Can heat zap lung tumors without surgery?
NCT ID NCT00180856
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This trial tests whether radiofrequency ablation—a procedure that uses heat to destroy cancer cells—can effectively treat lung tumors that cannot be removed with surgery. The study includes people with primary lung cancer or lung metastases, with up to five tumors each no larger than 40 mm. Researchers will measure how completely the tumors are destroyed, how long patients live without lung disease progression, and overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Radiofrequency ablation, a procedure that uses heat to destroy tumor cells
- What this could lead to
- If successful, this could offer a treatment option for people with lung tumors that cannot be surgically removed, potentially improving local control and survival.
- What could go wrong
- This is a phase II trial with a modest number of participants, so results may not be definitive. The procedure may not completely destroy all tumors, and there are risks of complications from the ablation itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Bergonié
Bordeaux, 33 000, France
-
Institut Gustave Roussy
Villejuif, 94800, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we spot cancer before it starts? a massive study aims to find out
- Can herbal plasters boost chemo nausea relief?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success